# Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription

> **NCT00244465** · — · COMPLETED · sponsor: **UCB Pharma** · enrollment: 750 (actual)

## Conditions studied

- Narcolepsy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00244465
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 750 (ACTUAL)
- **Last updated:** 2016-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244465, "Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00244465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*